Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
ID: 347720Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347720

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-145.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI) to support a comprehensive research program within an investigator's laboratory that aligns with the mission of the National Institute of General Medical Sciences (NIGMS). This funding opportunity encourages early independence in research careers by providing substantial funding of up to $250,000 per year for a maximum of five years, allowing investigators to explore innovative research avenues without the burden of preliminary data requirements. Eligible applicants must be NIH-defined ESIs and are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research efforts. Interested parties can find more information and apply electronically through Grants.gov, with the application deadline set for February 3, 2026. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-145-Full-Announcement.html
    PAR-23-145.html
    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (MIRA) for Early Stage Investigators (ESI) under the National Institute of General Medical Sciences (NIGMS). This funding opportunity aims to support a collective research program in an investigator's laboratory that aligns with NIGMS's mission. The MIRA encourages early independence in research careers by providing substantial funding, allowing flexibility to explore new research avenues without the burden of preliminary data requirements. Applicants can request up to $250,000 per year for a maximum of five years, with funding contingent on NIH appropriations. Eligible applicants must be NIH-defined ESIs, with the requirement to devote at least 51% of their research effort to the MIRA. A focus on diverse perspectives is mandated, with a Plan for Enhancing Diverse Perspectives (PEDP) needed to foster inclusivity and innovation in research. Applications are reviewed for scientific merit, significance, and the likelihood of launching sustainable research careers. This initiative reflects NIGMS's commitment to advancing a diverse and robust scientific workforce while increasing the overall productivity of biomedical research. The application process involves electronic submission via systems like Grants.gov, requiring several registrations and adherence to detailed instructions.
    Similar Opportunities
    Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) to support a broad program of research within the mission of the National Institute of General Medical Sciences (NIGMS). This grant aims to enhance the efficiency and efficacy of funding by providing stability and flexibility to investigators, allowing them to pursue diverse scientific inquiries over a five-year term, with funding levels capped at $750,000 in direct costs per year and typically set at $250,000 for New Investigators. The MIRA program is designed to reduce the application burden on researchers, encourage innovation, and foster diversity in the research workforce, with applications undergoing a rigorous peer review process. Interested applicants must submit their proposals by May 16, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Method to Extend Research in Time (MERIT) Award Extension, aimed at providing extended grant support to Early Stage Investigators (ESIs) who have shown strong research potential and received favorable evaluations on their R01 applications. This funding opportunity allows for up to seven years of support in two segments, enabling ESIs to establish their careers while focusing on critical cancer research areas such as identifying cancer risks, improving early detection strategies, and developing treatment methods. Interested applicants, including a diverse range of institutions such as Historically Black Colleges and Universities and Tribal Colleges, must adhere to specific application guidelines and register with Grants.gov and eRA Commons, with applications opening on February 3, 2025, and due by March 3, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Supporting Talented Early Career Researchers in Genomics," aimed at supporting innovative research projects led by Early Stage Investigators (ESIs) with a focus on genomics. This initiative encourages diverse applicants to propose research that aligns with the mission of the National Human Genome Research Institute (NHGRI), covering areas such as genomic sciences, genomic medicine, genomic data science, and the ethical implications of genomics. The program has a funding commitment of at least $2 million, with plans to award 3-5 grants, each with an annual budget cap of $400,000. Applications must be submitted electronically by February 26, 2027, and should include a detailed professional development plan and a resource sharing plan in compliance with NIH policies. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) to support innovative research projects led by early-stage investigators (ESIs) that represent a significant change in research direction without prior preliminary data. Applicants must submit proposals that do not include preliminary data and must describe the proposed shift in research focus, aligning with the missions of participating NIH Institutes and Centers. This grant aims to foster groundbreaking research and promote workforce diversity among ESIs from various backgrounds, including higher education institutions, nonprofits, and local governments. The application period opens on December 29, 2023, with a submission deadline of December 28, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-075.html.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support early-stage rehabilitation scientists in establishing independent research careers. This grant aims to fund a variety of research projects, including secondary data analysis, methodology development, and translational research, particularly those that can generate preliminary data for future R01 applications. The initiative is crucial for fostering innovative rehabilitation research and enhancing the diversity of research talent in the biomedical field. The maximum funding amount is $200,000 over two years, with applications due by May 8, 2026. Interested applicants can find more information and application details at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) to support innovative research projects by early stage investigators (ESIs) that represent a significant change in research direction without the inclusion of preliminary data. This grant aims to encourage ESIs to explore new avenues in basic science experimental studies involving human subjects, aligning with NIH's definition of clinical trials. The opportunity emphasizes diversity and inclusivity, inviting applications from a wide range of eligible applicants, including higher education institutions and community-based organizations, with application deadlines extending until December 29, 2026. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support rehabilitation scientists in establishing independent research careers. This grant aims to fund basic and clinical research projects that align with the mission of the National Center for Medical Rehabilitation Research (NCMRR), encouraging innovative studies in areas such as secondary data analysis, translational research, and the development of new technologies. The total estimated program funding is $200,000, with an award ceiling of $200,000, and applications are due by January 7, 2028. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
    Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH))
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award (K99/R00) to promote diversity within the biomedical research workforce. This grant aims to support early-career researchers from underrepresented backgrounds as they transition from mentored postdoctoral positions to independent faculty roles, with a focus on basic experimental studies involving human subjects that align with NIH's mission. The award consists of a two-year mentored training phase followed by a three-year independent research phase, contingent upon securing a faculty position. Applications are due by September 8, 2027, and interested applicants can seek guidance from NIH staff by contacting grantsinfo@nih.gov for further information.